By Benjamin Chiou
Date: Thursday 02 May 2024
(Sharecast News) - Moderna saw its share price surge on Thursday after posting a smaller-than-expected quarterly loss as the Covid vaccine maker sets its sights on regulatory approvals of its second product later in the year.
The pharma group, whose only commercial product to date was the Covid vaccine known as...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news